Like Promotional and Medical Audit Businesses

announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2018 via PR Newswire

ZS Associates, purchased BASES Pharmaceutical Forecasting from The Nielsen Company, Inc.

synopsis: ZS announced it has acquired the assets of BASES Pharmaceutical Forecasting from Nielsen. The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
buyer: ZS Associates
ZS Associates is a global management consulting firm specializing in sales and marketing strategy, operations and execution. Founded in 1983, ZS has grown into a firm of 500 professionals delivering expertise across much of the sales and marketing spectrum. "
seller: The Nielsen Company, Inc. (NLSN:$6,465.00)
The BASES Pharmaceutical Forecasting assets include launch product and direct-to-consumer forecasting tools and proprietary normative databases for pharmaceutical brands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/8/2012 via PR Newswire

Diversified Agency Services, will acquire Medical Collective Intelligence Co. Ltd.

synopsis: Diversified Agency Services announced an agreement with ITOCHU Corporation and a number of venture capital funds to acquire a majority stake in Medical Collective Intelligence Co. Ltd., a highly respected Japanese online medical communications agency.
buyer parent: Omnicom Group Inc.
buyer: Diversified Agency Services
Diversified Agency Services (DAS), a division of Omnicom Group Inc., manages Omnicom's holdings in a variety of marketing disciplines. DAS includes more than 190 companies, which operate through a combination of networks and regional organizations. "
target parent: Itochu Corporation
target: Medical Collective Intelligence Co. Ltd.
Medical Collective Intelligence Co. Ltd. ("MCI") is a highly respected and well-known Japanese online medical communications agency. Based in Tokyo, MCI operates a Marketing Research division and a Detailing Solutions division, both focused on the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2010 via BNC Analysis

United Drug plc, acquired InforMed Direct

synopsis: United Drug Plc, an Ireland-based healthcare services provider, has acquired the entire share capital of InforMed Direct Plc, a UK-based healthcare communications and market research agency, for a consideration of GBP11.4 million in cash.
buyer: United Drug plc (LSE:UDG:$1,298.52)
United Drug is a leading international healthcare services provider, employing 6,000 people in 35 businesses across Europe and the US. United Drug operates through 4 divisions. United Drug is a provider of services to pharmaceutical retailers and manufacturers. "
target: InforMed Direct
InforMed offers healthcare communications at every stage of the product lifecycle – from development and consultancy to tactical delivery. Its market research and business analysis division delivers quant and qual research, as well as forecasting and market simulation models.
price ($mm)
$18
rev ($mm)
$16
EBITDA ($mm)
EV / rev
1.7x
EV / EBITDA
closed 1/19/2010 via PR Newswire

Decision Resources, Inc., acquired BioTrends Research Group, Inc.

synopsis: Decision Resources, Inc., one of the world's leading research and advisory firms focusing on healthcare insights and analysis, announced that it acquired BioTrends Research Group, the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: BioTrends Research Group, Inc.
BioTrends Research Group, Inc. provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2008 via PR Newswire

Quintiles Transnational Corp., will acquire Eidetics

synopsis: Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs. "
target: Eidetics
Eidetics is being acquired by Quintiles. A market research and consulting company serving the world's leading pharmaceutical, biotechnology, and medical device companies. Headquartered in Boston, we have extensive international resources to address the global nature of today's marketing challenges.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via PR Newswire

Decision Resources, Inc., acquired Arlington Medical Resources Inc.

synopsis: Berkery Noyes, the leading independent investment bank serving the media, information and technology markets, announces that it represented Arlington Medical Resources, Inc. in its sale to Decision Resources, Inc., a portfolio company of Providence Equity Partners, Inc. Terms of the transaction were not disclosed.
buyer parent: Providence Equity Partners Inc.
buyer: Decision Resources, Inc.
Decision Resources, Inc. is a world leader in research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources consists of the medical technology business unit and the biopharma business unit. "
target: Arlington Medical Resources Inc.
AMR is a privately held pharmaceutical market research firm headquartered in suburban Philadelphia. We have been serving the market research needs of the pharmaceutical & diagnostic imaging industries since 1988.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/22/2004 via PR Newswire

Ventiv Health, acquired HHI Clinical Research & Statistical Services, L.L.C.

synopsis: Ventiv Health, Inc. VTIV, a leading provider of late-stage clinical, sales, marketing and compliance services to pharmaceutical and biotech organizations, today announced that it has successfully completed the acquisition of HHI Clinical & Statistical Research Services, L.L.C.
buyer: Ventiv Health
inVentiv Health, Inc. is the leading provider of commercialization and complementary services to the global pharmaceutical, life sciences and biotechnology industries. inVentiv delivers its customized clinical, sales, marketing and communications solutions. "
target: HHI Clinical Research & Statistical Services, L.L.C.
HHI Clinical Research & Statistical Services, L.L.C. is a focused clinical service provider managing statistical analysis and data management functions for pharmaceutical and biotechnology companies. HHI's services include data support, programming, statistical analysis and report writing. HHI has
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/16/2004 via PR Newswire

Thomson Scientific & Healthcare, acquired Newport Strategies, Inc.

synopsis: The Thomson Corporation announced that it has acquired Newport Strategies, Inc., a leading provider of competitive intelligence for the pharmaceutical industry. Newport Strategies will become part of the scientific business within the Thomson Scientific and Healthcare market group.
buyer parent: The Thomson Corporation
buyer: Thomson Scientific & Healthcare (:$964.58)
Thomson Scientific & Healthcare provides integrated information solutions to researchers and librarians, physicians and pharmacists, and other professionals worldwide. "
target: Newport Strategies, Inc.
Newport develops and markets cutting-edge systems that deliver the earliest and most reliable source of global intelligence on competition for launched pharmaceutical products. Innovator, generic and specialty pharmaceutical companies worldwide use Newport's systems and expert confidential consulti
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/26/2005 via PR Newswire

Greenfield Online, Inc., acquired Rapidata.net, Inc.

synopsis: Greenfield Online, Inc SRVY, a leading provider of Internet survey solutions to marketing research and consulting companies, today announced it has completed the acquisition of Rapidata.net, Inc., a privately-held North Carolina corporation, for $5.5 million in cash, subject to certain post closing adjustments.
buyer: Greenfield Online, Inc. (SRVY:$0.00)
Greenfield Online, Inc. is a global interactive media and services company that collects consumer attitudes about products and services, enabling consumers to reach informed purchasing decisions about the products and services they want to buy; and helping companies better understand their customer."
target: Rapidata.net, Inc.
Founded fifteen years ago by research pharmacist and professor David P. Lipson, R.PH., Ph.D., Rapidata.net connects pharmaceutical market researchers to healthcare providers and their patients. This connection allows pharmaceutical market researchers to learn more about the prescription medications
price ($mm)
$5.50
rev ($mm)
$2
EBITDA ($mm)
EV / rev
2.6x
EV / EBITDA
closed 9/25/2020 via BusinessWire

W2O Group, acquired Elysia Group

synopsis: W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, announced it has acquired Elysia Group, a health economic and outcomes research (HEOR) consulting firm operating in the United States and Asia Pacific.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: Elysia Group
Elysia Group is a health economic and outcomes research consulting firm. Elysia provides pharmaceutical and medical device clients with innovative modeling approaches to health economic strategy and evidence development using data and analytics and real-world evidence.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/25/2012 via PR Newswire

McCann Health, acquired Double Helix

synopsis: McCann Health announced the acquisition of Double Helix. Double Helix is a leading, global provider of Market Research and Market Access services to the pharmaceutical and medical device industries. Dr. Wayne Phillips, who founded and runs Double Helix, will continue as CEO of Double Helix, reporting to John Cahill, CEO of McCann Health.
buyer parent: Interpublic Group of Companies, Inc.
buyer: McCann Health
Comprising the world's most connected health and wellness experts, McCann Health is the most awarded professional and consumer health communications network with the largest international expertise spanning 35 countries and 61 offices. "
target: Double Helix
Double Helix is an independent healthcare consultancy with headquarters in London and offices in the US and Singapore. Established in 1995, they have been providing pharmaceutical, biotech and medical device clients of all sizes with the knowledge to evolve their brands and businesses.
price ($mm)
$55
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/14/2009 via BusinessWire

Majestic Research, LLC, acquired Rood Research, Inc.

synopsis: Majestic Research, a global, independent equity research company and a pioneer in data driven analysis, announced its acquisition of New York-based Rood Research – a leading provider of healthcare market research.
buyer: Majestic Research, LLC
Since its inception in 2002, Majestic Research has revolutionized the financial research business with our innovative proprietary methods and tools for accessing real-time data. "
target: Rood Research, Inc.
In the past 15 years, Rood Research has become a leader in providing healthcare research to some of the top pharmaceutical and biotech companies in the world.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2008 via BusinessWire

Surveillance Data, Inc., acquired Verispan, LLC

synopsis: SDI, the leader in innovative healthcare analytics, has acquired Verispan, a top provider of healthcare information and services. The acquisition creates the healthcare industry’s most comprehensive de-identified longitudinal database.
buyer parent: LLR Partners
buyer: Surveillance Data, Inc.
SDI provides a wide range of healthcare data and market research to pharmaceutical, consumer products, and healthcare-related companies. Since 1981, SDI's mission has been to provide healthcare data products with high business relevance as well as the means and know-how to put this data into action."
target: Verispan, LLC
Verispan provides a broad array of information products and services to virtually all of the top 50 pharmaceutical companies and the healthcare industry in general, including sales targeting and compensation products; market research audits; healthcare profiles; and direct mail, among many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2020 via PR Newswire

Medical Knowledge Group LLC, acquired Magnolia Innovation, LLC

synopsis: Medical Knowledge Group, LLC, an analytics-driven and technology-enabled multichannel health care marketing and communications conglomerate whose operating companies serve the biopharmaceutical industry, has acquired Magnolia Innovation, a premier market research and strategy consulting firm.
buyer parent: Court Square Capital Partners
buyer: Medical Knowledge Group LLC
Medical Knowledge Group, through its operating companies, provides specialized medical communications services, proprietary analytic solutions, and market research services to the biopharmaceutical industry. "
target: Magnolia Innovation, LLC
Magnolia Innovation is a market research and consulting firm focusing exclusively in the life sciences. Magnolia has decades of combined experience building, launching, and redefining biopharmaceutical brands to drive innovation through insights.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 11/16/2018 via Company Press Release

Vestar Capital Partners, will acquire Information Resources, Inc.

synopsis: Vestar Capital Partners, a private equity firm, will lead a new investment in Information Resources, Inc., a leading provider of big data, predictive analytics and forward-looking insights. Jeffrey Ansell, a Vestar Senior Advisor, will serve as Chairman of IRI. New Mountain and other existing investors are retaining a meaningful investment in IRI.
buyer: Vestar Capital Partners
Vestar Capital Partners (VCP) is a private equity firm specializing in management buyouts and growth capital investments. VCP collaborates with management teams and private owners to build long- term enterprise value, with a focus on Consumer, Healthcare, and Business Services & Industrial Products."
target parent: New Mountain Capital, LLC
target: Information Resources, Inc.
Information Resources, Inc. is a leading provider of big data, predictive analytics and forward-looking insights that help CPG companies, OTC health care organizations, retailers, financial services and media companies grow their businesses.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2018 via Company Press Release

BioInformatics Inc., acquired Kalorama Information

synopsis: BioInformatics Inc., the premier research and advisory company serving the life science industry, has acquired Kalorama Information from MarketResearch. Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics, imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target parent: MarketResearch.com, Inc.
target: Kalorama Information
Kalorama Information is a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals. Kalorama only publishes in healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Health Strategies Group

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Health Strategies Group. Health Strategies Group is the leader in market access intelligence and customized research for pharmaceutical and biotech professionals. It dissects trends and identifies opportunities to help companies optimize their product access.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Health Strategies Group
Health Strategies Group offers a dedicated team of research leaders committed to dissecting the trends, identifying customer needs, and pinpointing the barriers and opportunities for biopharma within the evolving health care environment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/1/2011 via BNC Analysis

IMS Health Incorporated, acquired SDI Health LLC

synopsis: IMS Health has completed its acquisition of SDI, a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations. "
target parent: LLR Partners
target: SDI Health LLC
SDI is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
$340
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/30/2008 via BusinessWire

Surveillance Data, Inc., acquired Verispan, LLC

synopsis: SDI, the leader in innovative healthcare analytics, has acquired Verispan, a top provider of healthcare information and services. The acquisition creates the healthcare industry’s most comprehensive de-identified longitudinal database.
buyer parent: LLR Partners
buyer: Surveillance Data, Inc.
SDI provides a wide range of healthcare data and market research to pharmaceutical, consumer products, and healthcare-related companies. Since 1981, SDI's mission has been to provide healthcare data products with high business relevance as well as the means and know-how to put this data into action."
target: Verispan, LLC
Verispan provides a broad array of information products and services to virtually all of the top 50 pharmaceutical companies and the healthcare industry in general, including sales targeting and compensation products; market research audits; healthcare profiles; and direct mail, among many others.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/15/2005 via BusinessWire

Video Monitoring Services of America, LP, acquired PRtrak

synopsis: Video Monitoring Services (VMS), the world leader in news and advertising monitoring and analysis services, today announced that it has acquired media analysis and measurement innovator PRtrak, expanding the breadth and depth of VMS' Integrated Media Intelligence (IMI) solutions portfolio.
buyer: Video Monitoring Services of America, LP
VMS is a world leader in the retrieval, management and analysis of news and advertising information providing unique services and products for public relations firms, advertising agencies and marketers worldwide. VMS' global advertising database is the largest in the world containing over 3 million "
target parent: Surveillance Data, Inc.
target: PRtrak
PRtrak has developed a stable of software tools & services that focuses on the link between competitive media coverage & business outcomes through innovative research & precision metrics. Their products help professionals demonstrate the value of their work in terms management understands.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 1/17/2012 via PR Newswire

Campbell Alliance Group, Inc., will purchase Promotional and Medical Audit Businesses from SDI Health LLC

synopsis: inVentiv Health, Inc. has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in connection with obtaining regulatory approval of its acquisition of SDI.
buyer parent: Thomas H. Lee Partners, L.P.
buyer: Campbell Alliance Group, Inc.
Campbell Alliance is the Consulting business segment of inVentiv Health, a leading global provider of best-in-class clinical, commercial, and consulting services to companies seeking to accelerate performance. "
seller parent: TPG Capital
seller: SDI Health LLC
SDI Health is a leading healthcare market insight and analytics firm. It provides the industry’s most comprehensive de-identified patient-level data to pharmaceutical, biotech, and medical device companies, enabling them to better understand the healthcare market.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2009 via PR Newswire

Pharmaceutical Institute, acquired GeneEd, Inc.

synopsis: Pharmaceutical Institute announced that it has acquired e-learning assets from GeneEd, Inc., a company specializing in life science courseware. These assets, including 155 highly advanced e-courses, help expand Pharmaceutical Institute's already extensive library of training resources.
buyer parent: Campbell Alliance Group, Inc.
buyer: Pharmaceutical Institute
Pharmaceutical Institute is a leading provider of specialized training programs for the pharmaceutical and biotech industry. They partner with subject matter experts from Campbell Alliance, the parent company, to develop highly impactful dstance learning solutions for pharma professionals. "
target: GeneEd, Inc.
GeneEd is a provider of life science e-learning content.Two scientists and a retired venture capitalist founded GeneEd in 1997. Dr. Sunil Maulik and Dr. Salil Patel have more than 15 years of industry and teaching experience at Roche Bioscience, Doubletwist and other life science companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 10/27/2020 via BusinessWire

Accenture, will acquire OpusLine

synopsis: Accenture has entered into an agreement to acquire Paris-based OpusLine, one of the leading consulting companies that provides strategic advisory and transformational services to public- and private-sector healthcare providers as well as life sciences and insurance companies in France.
buyer: Accenture (ACN:$44,327.04)
Accenture is a global professional services company with leading capabilities in digital, cloud, and security. Accenture offers Strategy and Consulting, Interactive, Technology, and Operations services powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. "
target: OpusLine
OpusLine is one of the leading consulting companies that provides strategic advisory and transformational services to public- and private-sector healthcare providers as well as life sciences and insurance companies in France.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/31/2006 via BusinessWire

National Research Corporation, acquired Governance Institute

synopsis: National Research Corporation, a leader in healthcare performance measurement and improvement, today announced the purchase of substantially all of the assets of The Governance Institute (TGI), a portfolio company of Housatonic Partners.
buyer: National Research Corporation (NRCI.B:$101.10)
Founded in 1981, National Research Corporation (NRC) has maintained a strong commitment to improving the quality of healthcare received by patients and consumers through a focus on continual improvement in patient experience and performance measurement within the healthcare industry. "
target parent: Housatonic Partners
target: Governance Institute
Recognized nationally as the preeminent source for unbiased governance knowledge, The Governance Institute conducts research studies, tracks healthcare industry trends, and showcases the best practices of leading healthcare boards across the country.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/3/2015 via PR Newswire

Publicis Touchpoint Solutions, Inc., acquired Tardis Medical Consultancy

synopsis: Publicis Healthcare (PHCG) announced that it has acquired Tardis Medical, a highly respected clinical and medical affairs outsourcing organization and consultancy business. The agency will be aligned with Publicis Touchpoint Solutions, part of PHCG, Inc—a leading provider of customized, omnichannel healthcare sales, service, and clinical teams.
buyer parent: Publicis Groupe SA
buyer: Publicis Touchpoint Solutions, Inc.
Publicis Touchpoint Solutions designs and implements customized healthcare sales, service, and communications teams. They provide field sales and service, live video detailing, inside credentialed sales specialists, inside sales and service, clinical health educators, and medical science liaisons. "
target: Tardis Medical Consultancy
Tardis Medical is a Clinical and Medical Affairs consultancy, enabling pharmaceutical and life sciences companies to work as effectively as possible through: consultancy on strategic issues and operational matters, capabilities development, and resource augmentation of field based consultants.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/6/2017 via Company Press Release

The Access Group, acquired Alliance Life Sciences

synopsis: Water Street Healthcare Partners, through its subsidiary, The Access Group, has acquired Alliance Life Sciences. Alliance specializes in maximizing revenue and optimizing pricing for its customers. The firm offers global pricing analytic tools and data, outsourced contract and revenue management services and digital marketing operational services.
buyer parent: Water Street Healthcare Partners
buyer: The Access Group
The Access Group offers a breadth of services to clients, from traditional “block-and-tackle” launch execution tactics to in-depth market assessments. The company is dedicated to complete product life cycle management, creating brand solutions that drive demand across multiple stakeholder channels. "
target: Alliance Life Sciences
Alliance Life Sciences is a global innovator that delivers peace of mind and unlocks business value with unique solutions to complex commercial problems. Its worldwide team of experts provides insights and solves problems in contracting, pricing, reimbursement, and commercial operations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/29/2019 via Company Press Release

Netsmart Technologies, Inc., acquired McBee Associates, Inc.

synopsis: Healthcare IT provider Netsmart announced it has acquired Pennsylvania-based healthcare consulting firm, McBee. McBee’s industry-leading healthcare professional services will provide community and acute care organizations with nearly a century of advisory and technology experience under one roof.
buyer parent: GI Partners
buyer: Netsmart Technologies, Inc. (:$59.05)
Netsmart designs, builds and delivers electronic health records (EHRs), solutions and services that are powerful, intuitive and easy-to-use.Their platform provides accurate, up-to-date information that is easily accessible to care team members in behavioral health. "
target parent: Century Equity Partners
target: McBee Associates, Inc.
McBee is the nation’s premier health care services and consulting firm that delivers financial, operational, and clinical consulting services exclusively to healthcare providers across the continuum of care.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/22/2014 via GlobeNewswire

MedAssets Inc., acquired Sg2, LLC

synopsis: MedAssets today announced that it completed its previously announced acquisition of SG-2, LLC (Sg2), a leading provider of healthcare business intelligence, market analytics and clinical consulting services.
buyer parent: Parthenon Capital Partners
buyer: MedAssets Inc. (MDAS:$764.22)
MedAssets is a healthcare performance improvement company focused on helping providers realize financial and operational gains. More than 4,400 hospitals and 122,000 non-acute healthcare providers currently use the company's evidence-based solutions, best practice processes and analytics. "
target: Sg2, LLC
Sg2 is a leading provider of healthcare market intelligence, strategic analytics and clinical consulting services that help more than 1,400 hospitals, health systems, as well as pharmaceutical and medical device companies understand current and future market dynamics.
price ($mm)
$125
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/1/2005 via PR Newswire

FTI Consulting, Inc., acquired Cambio Health Solutions, LLC

synopsis: FTI Consulting, Inc., the premier provider of corporate finance/restructuring, forensic/litigation/technology and economic consulting, today announced that it has completed its previously announced acquisition of the assets of privately-held Cambio Health Solutions, LLC.
buyer: FTI Consulting, Inc. (FCN:$2,406.04)
FTI Consulting, Inc. is a global business advisory firm dedicated to helping organizations protect and enhance enterprise value in an increasingly complex legal, regulatory and economic environment. "
target: Cambio Health Solutions, LLC
FTI Healthcare is a leading provider of change management, financial advisory and specialized consulting services to healthcare providers and other healthcare businesses.
price ($mm)
$43
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2019 via PR Newswire

The WIRB-Copernicus Group, acquired Waife & Associates, Inc.

synopsis: WIRB-Copernicus Group (WCG) has acquired Waife & Associates, Inc. (W&A), a provider of management consulting services for biopharmaceutical clinical research clients. W&A focuses on making clinical development more efficient and productive through improvements in organization, process, and technology.
buyer parent: Arsenal Capital Partners
buyer: The WIRB-Copernicus Group
WCG (WIRB-Copernicus Group) is the world's leading provider of solutions that improve the quality and efficiency of clinical research. WCG enables biopharmaceutical companies, clinical research organizations, and institutions to accelerate the delivery of new treatments and therapies to patients. "
target: Waife & Associates, Inc.
Waife & Associates (W&A) provides the clinical research industry with management and operational consulting delivered with senior domain expertise. W&A designs cost-effective solutions for clinical operations and data management, and all related functions and software technologies involved.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/27/2013 via Company Press Release

Cumberland, purchased Life Sciences Consulting Division from Mindlance

synopsis: Cumberland Consulting Group LLC, has purchased the Mindlance Life Sciences Consulting division of Mindlance Inc., a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
buyer parent: Tailwind Capital Partners
buyer: Cumberland
Cumberland Consulting provides healthcare IT consulting services, including, Planning & Assessment; Workflow Management; Vendor Selection; Software Implementation; and Project Management to healthcare organizations. "
seller: Mindlance
Mindlance Inc., is a staffing, application, and infrastructure management firm. The Mindlance Life Sciences Consulting division provides services to pharmaceutical companies specializing in contract and revenue management, compliance and data analytics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2017 via PR Newswire

IntegriChain, Inc., acquired PharmaMetrics, Inc.

synopsis: IntegriChain, a rapidly growing healthcare technology company, announced the acquisition of PharmaMetrics, a leading provider of contract operations outsourcing and market access analytics software and services.
buyer parent: Accel-KKR
buyer: IntegriChain, Inc.
IntegriChain is a rapidly growing cloud software company focused on channel management for life sciences suppliers. Health suppliers use IntegriChain to manage their supply chain relationships, inventories, and orders across a vast network of retailers, ecommerce, and distributors. "
target: PharmaMetrics, Inc.
PharmaMetrics is a leading provider of contract operations business process outsourcing and market access analytics, software, and services. PharmaMetrics delivers contract operations services including Medicaid processing, commercial processing, Medicare Part D, chargebacks, and government pricing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/28/2020 via BusinessWire

W2O Group, acquired Discern Health

synopsis: W2O, the leading independent provider of analytics-driven, technology-enabled marketing and communications solutions to the healthcare sector, acquired Discern Health, a company that counsels leading healthcare organizations on the performance measures and innovative payment models that shape the market for their products and services.
buyer parent: New Mountain Capital, LLC
buyer: W2O Group
W2O is an independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector. W2O applies analytics models, methodologies and approaches in a digital world to design precise communications and marketing strategies to deliver sustained business results. "
target: Discern Health
Discern Health counsels leading healthcare organizations on the performance measures and innovative payment models that shape the market for their products and services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/11/2019 via PR Newswire

Indegene Lifesystems Pvt Ltd., acquired DT Associates

synopsis: Indegene, a global next-generation solutions company in the Life Sciences industry, has acquired London-based DT Associates, a consulting company focused on helping pharmaceutical companies achieve excellence in Customer Experience and Digital Operations. DT Associates will operate as a separate entity in Indegene Private Ltd, as DT Consulting.
buyer: Indegene Lifesystems Pvt Ltd.
Indegene enables global health care companies to address complex challenges and drive better health and business outcomes by integrating analytics, technology, operations, and medical expertise. Indegene drives innovation by combining medical expertise with contemporary digital and AI technologies. "
target: DT Associates
London-based DT Associates helps pharmaceutical firms achieve digital excellence to create successful customer experiences. DT uses fact-based insights from curated research, assessments, benchmarks, consulting projects, and more to address digital transformation in the pharmaceutical industry.
price ($mm)
$12
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/21/2019 via Company Press Release

UDG Healthcare plc, acquired Putnam Associates

synopsis: UDG Healthcare plc, a leading international healthcare services provider, announces the acquisition of Putnam Associates, a company that provides strategic advice based on sophisticated and robust analytics to biopharmaceutical, diagnostics, and medical device clients.
buyer: UDG Healthcare plc (LSE:UDG:$1,298.52)
UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. The Group is organised and managed across two divisions: Ashfield and Sharp, and employs 8,700 people in 26 countries. "
target: Putnam Associates
Putnam Associates serves global biopharmaceutical, diagnostics, and medical device clients, along with private equity and venture capital clients, providing world class strategic advice based on sophisticated, robust analytics.
price ($mm)
$60
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/21/2018 via BusinessWire

GHO Capital, acquired Validant

synopsis: GHO Capital, the European specialist investor in healthcare, has acquired a majority stake in Validant. Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
buyer: GHO Capital
Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London. They apply global capabilities and perspectives to unlock high growth healthcare opportunities in Europe, building market leading businesses of strategic global value."
target: Validant
Operating globally with offices in Europe and North America, Validant provides specialist consulting services, with a focus on quality, compliance and regulatory affairs, to a broad range of clients across the biotech, pharma and medtech sectors.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 9/7/2018 via BNC Analysis

Ancor Capital Partners, acquired STATinMed

synopsis: Ancor Capital Partners, a Dallas-based private equity firm, announces the acquisition of STATinMED Research, a leading medical technology company in the health economics and outcomes research industry. STATinMED provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies.
buyer: Ancor Capital Partners
Ancor Capital Partners is an operations-oriented private equity firm focused on lower middle-market companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. "
target: STATinMed
STATinMED Research provides research, consulting, and targeted communications to global pharmaceutical, biotechnology, and health information companies. All STATinMED Research consultants hold academic positions with prestigious universities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/30/2016 via BNC Analysis

Wilmington plc, will acquire Evantage Consulting Ltd

synopsis: Wilmington PLC has struck a deal worth to acquire healthcare and pharmaceutical analytics firm Evantage Consulting Ltd. Evantage is the North American training partner for Axure, and helps clients around the country master Axure RP, an industry-leading rapid prototyping tool for communicating and testing UI designs.
buyer: Wilmington plc (LSE:WIL:$162.62)
Wilmington plc is a dynamic and expanding group of companies providing information and training to professional business markets. Its businesses enable professionals and their organisations to perform better by providing quality, relevant and reliable information, education and knowledge. "
target: Evantage Consulting Ltd
Evantage Consulting Ltd. is a healthcare and pharmaceutical analytics firm. Evantage is the North American training partner for Axure, and helps clients around the country master Axure RP, an industry-leading rapid prototyping tool for communicating and testing UI designs.
price ($mm)
$1.98
rev ($mm)
$2
EBITDA ($mm)
EV / rev
5.5x
EV / EBITDA
announced 12/19/2013 via BusinessWire

Huron Consulting Group Inc., will acquire The Frankel Group Associates LLC

synopsis: Huron Consulting Group, a leading provider of business consulting services, announced that it has entered into an agreement to acquire the assets of The Frankel Group Associates LLC, a life sciences consulting firm. The acquisition will expand Huron’s strategy, advanced analytics, and regulatory compliance offerings to life sciences clients.
buyer: Huron Consulting Group Inc. (HURN:$892.03)
Huron Consulting Group helps clients in diverse industries improve performance, comply with complex regulations, reduce costs, recover from distress, leverage technology, and stimulate growth. The Company teams with its clients to deliver sustainable and measurable results. "
target: The Frankel Group Associates LLC
Frankel Group is a leading strategy consulting firm with offices in New York City, Cambridge, Massachusetts, and Tel Aviv, Israel that has served the life science industry and related segments since 1993.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/2/2013 via Company Press Release

Press Ganey Associates, Inc., acquired Morehead Associates

synopsis: Press Ganey Associates, Inc., a recognized leader in health care performance improvement, announced that it acquired Morehead Associates, Inc., one of the industry’s foremost employee and physician engagement firms. The acquisition strengthens Press Ganey’s comprehensive suite of patient experience solutions and services.
buyer parent: Vestar Capital Partners
buyer: Press Ganey Associates, Inc. (PGND:$344.32)
Recognized as a leader in performance improvement, Press Ganey partners with more than 10,000 health care organizations worldwide to create and sustain high performing organizations, and, ultimately, improve the overall health care experience. "
target: Morehead Associates
Morehead Associates helps leaders make better decisions and drive performance. They partner with healthcare organizations to create an engaged workforce, prioritize systemic changes, and align employees and physicians with business strategies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Promotional and Medical Audit Businesses


read more

SDI Health LLC

The Nielsen Company, Inc.

Medical Collective Intelligence Co. Ltd.

PharmARC Analytic Solutions Pvt. Ltd.

SDI Health LLC

InforMed Direct

BioTrends Research Group, Inc.

Eidetics

Arlington Medical Resources Inc.

HHI Clinical Research & Statistical Services, L.L.C.

Newport Strategies, Inc.

Rapidata.net, Inc.

Elysia Group

Double Helix

Rood Research, Inc.

Verispan, LLC

Magnolia Innovation, LLC

Information Resources, Inc.

Kalorama Information

Health Strategies Group

read more

SDI Health LLC

SDI Health LLC

Verispan, LLC

PRtrak

read more

SDI Health LLC

GeneEd, Inc.

read more

OpusLine

Governance Institute

Tardis Medical Consultancy

Alliance Life Sciences

PharmARC Analytic Solutions Pvt. Ltd.

McBee Associates, Inc.

Sg2, LLC

Cambio Health Solutions, LLC

Waife & Associates, Inc.

Mindlance

PharmaMetrics, Inc.

Discern Health

DT Associates

Putnam Associates

Tri Stat

Validant

STATinMed

Evantage Consulting Ltd

The Frankel Group Associates LLC

Morehead Associates

Geography
Matching Companies